Julianne Chen
About
Julianne Chen is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology.
According to data from OpenAlex, Julianne Chen has authored 58 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hematology, 19 papers in Public Health, Environmental and Occupational Health and 14 papers in Oncology. Recurrent topics in Julianne Chen's work include Hematopoietic Stem Cell Transplantation (45 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (19 papers). Julianne Chen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (45 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (19 papers). Julianne Chen collaborates with scholars based in United States, Thailand and Japan. Julianne Chen's co-authors include Richard E. Champlin, Gabriela Rondón, Michael Andreeff, Jennifer L. Dembinski, Joy Gumin, Matus Studeny, Asadullah Khan, Frederick F. Lang, Toshiyuki Amano and Stephen J. Hentschel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.
In The Last Decade
Julianne Chen
57 papers receiving 2.2k citations
Hit Papers
Peers
Julianne Chen
Patrick Wuchter Germany
Myrtle Y. Gordon United Kingdom
Fernando Anjos‐Afonso United Kingdom
Jianyu Weng China
Jonathan M. Weber United States
Marja Ekblom Sweden
Hermann Kreyenberg Germany
Stephen Grupp United States
Selim Kuçi Germany
MJ Fackler United States
Citations per year, relative to Julianne Chen Julianne Chen (= 1×)
peers
Patrick Wuchter
Countries citing papers authored by Julianne Chen
Since
Specialization
Citations
This map shows the geographic impact of Julianne Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julianne Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julianne Chen more than expected).
Fields of papers citing papers by Julianne Chen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Julianne Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julianne Chen. The network helps show where Julianne Chen may publish in the future.
Co-authorship network of co-authors of Julianne Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Julianne Chen. A scholar is included among the top collaborators of Julianne Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julianne Chen. Julianne Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ciurea, Stefan O., Uday Popat, Jeremy Ramdial, et al.. (2024). Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies. Blood Advances. 8(12). 3237–3245.
2.
Ciurea, Stefan O., Jolie Schafer, Piyanuch Kongtim, et al.. (2021). Results of a Phase I Study with Mb-IL21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Refractory Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 27(3). S77–S78.
3.
Ciurea, Stefan O., Monzr M. Al Malki, Piyanuch Kongtim, et al.. (2021). Treatment of allosensitized patients receiving allogeneic transplantation. Blood Advances. 5(20). 4031–4043.
4.
Oran, Betül, Rima M. Saliba, Rohtesh S. Mehta, et al.. (2021). Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer. 127(10). 1598–1605.
5.
Ciurea, Stefan O., Piyanuch Kongtim, Ankur Varma, et al.. (2019). Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?. Blood. 135(6). 449–452.
6.
Kongtim, Piyanuch, Omar Hasan, Ankur Varma, et al.. (2019). Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(1). 197–203.
7.
Zeng, Zhihong, Wenbin Liu, Christopher B. Benton, et al.. (2019). Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation. Acta Haematologica. 142(3). 176–184.
8.
Kongtim, Piyanuch, Simrit Parmar, Denái R. Milton, et al.. (2018). Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplantation. 54(6). 839–848.
9.
Shah, Mithun Vinod, Rima M. Saliba, Gabriela Rondón, et al.. (2018). Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplantation. 54(4). 601–606.
10.
Ciurea, Stefan O., Jolie Schafer, Roland L. Bassett, et al.. (2017). Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation. Blood. 130(16). 1857–1868.
11.
Mehta, Rohtesh S., Rima M. Saliba, Kai Cao, et al.. (2017). Ex Vivo Mesenchymal Precursor Cell–Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery. Biology of Blood and Marrow Transplantation. 23(8). 1359–1366.
12.
Rondón, Gabriela, Rima M. Saliba, Julianne Chen, et al.. (2017). Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes. Biology of Blood and Marrow Transplantation. 23(12). 2166–2171.
13.
Hammerstrom, Aimee, Sai Ravi Pingali, Gabriela Rondón, et al.. (2017). Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(2). 353–358.
14.
Oran, Betül, Jeff Jorgensen, David Marín, et al.. (2016). Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica. 102(1). 110–117.
15.
Alousi, Amin M., Jonathan E. Brammer, Rima M. Saliba, et al.. (2015). Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies. Biology of Blood and Marrow Transplantation. 21(5). 906–912.
16.
Lee, Hans C., Rima M. Saliba, Gabriela Rondón, et al.. (2015). Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation. 21(11). 1948–1954.
17.
Saliba, Rima M., Katayoun Rezvani, Ann M. Leen, et al.. (2015). General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 21(7). 1284–1290.
18.
Bayraktar, Ulas D., Denái R. Milton, Michele Guindani, et al.. (2015). Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation. 22(3). 505–513.
19.
Kongtim, Piyanuch, Antonio Di Stasi, Gabriela Rondón, et al.. (2014). Can a Female Donor for a Male Recipient Decrease the Relapse Rate for Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation?. Biology of Blood and Marrow Transplantation. 21(4). 713–719.
20.
Sharma, Manish, Farhad Ravandi, Ulas D. Bayraktar, et al.. (2011). Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib. Biology of Blood and Marrow Transplantation. 17(12). 1874–1877.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Patrick Wuchter Breakdown of academic impact, for papers by Myrtle Y. Gordon Breakdown of academic impact, for papers by Fernando Anjos‐Afonso Breakdown of academic impact, for papers by Jianyu Weng Breakdown of academic impact, for papers by Jonathan M. Weber Breakdown of academic impact, for papers by Marja Ekblom Breakdown of academic impact, for papers by Hermann Kreyenberg Breakdown of academic impact, for papers by Stephen Grupp Breakdown of academic impact, for papers by Selim Kuçi Breakdown of academic impact, for papers by MJ Fackler